AFMD (affimed.com) Net Profit

AFMD (affimed.com) - company brandmark

High costs associated with AI antibody screening are creating financial pressure, which is evident in the current earnings of Affimed (AFMD). The 0.00 mark indicates the current state of this metric. Robotic molecule synthesis, which reduces headcount, mitigates these risks. However, a lack of sales leaves the business dependent on external grants and tranches from major partners, which determines the overall stability of the asset.

AFMD (Affimed) Net Profit history from 07/04/2022 to 05/31/2025

Analytical breakdowns and data insights for company affimed.com (AFMD)

- price and consensus price forecast:
Stock Quotes Affimed N.V.|AFMD - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization AFMD|AFMD - Real Price to Acquire Entire Company
- book capitalization data:
Accounting Value of a Share Affimed|AFMD - Book Capitalization|Market Capitalization to Book Value affimed.com|AFMD - Aggregate Company Assets
- debt and solvency information:
Total Debt to Equity Ratio Affimed|AFMD - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Affimed N.V.|AFMD - Company Total Debt|Debts to Book Capitalization AFMD|AFMD - Company Long-Term Debt|Company Short-Term Indebtedness Affimed|Immediate Liquidity affimed.com
- net income and valuation multiples indicators:
AFMD - Net Profit
Summary company analysis:Affimed
Core merchandise of Affimed NV

This metric reflects the daily market consensus regarding the company's actual net income, excluding quarterly gaps to identify hidden revenue stagnation. An analysis of Affimed (AFMD) balance sheet profits allows for the timely detection of a financial downturn, which is critical for Affimed (AFMD), as the monetization rates of its drugs are being hindered by logistical disruptions and geopolitical barriers during the conduct of global clinical trials.

Main competitors

Net Income argenx BVBA|BNTX (BioNTech SE) - Net Profit|Net Profit Abivax Pharma|Net Income ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Final Profit|Net Profit IMVT (Immunovant Corp)|Net Financial Result Kiniksa Corp (KNSA)|GRFS - Company Net Income|adaptivebiotech.com (ADPT) - Net Income|Celldex Therapeutics, Inc. (CLDX) - Company Net Income|Net Income Aurinia Pharmaceuticals Inc|Net Income BCRX|Net Profit Vera Corp|Company Net Income Dianthus Therapeutics (DNTH)|pharvaris.com - Company Profit|Net Profit ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Company Net Income|Intrexon - Net Profit|PHAR - Net Profit|NKTR: Net Profit|Profit After Tax UPB (upstreambio.com)|ZBIO (Zenas Biopharma) - Net Profit|Immunome Inc - Profit After Tax|Net Profit GOSS|Net Financial Result KalVista Corp|Company Net Income Septerna Inc SEPN|PVLA - Net Income|Savara - Net Profit|Company Net Income Rigel Pharma|ANAB: Net Profit|Company Profit ATXS|ENGN (enGene Holdings Inc.) - Net Profit|Net Profit rapt.com|Net Profit JBIO|ACRS: Profit After Tax|Company Net Income Kyverna KYTX|TLSA - Net Income|Cabaletta Bio, Inc. - Net Profit|VTYX (ventyxbio.com) - Company Profit|Theratechnologies (THTX) - Company Net Income|Profit After Tax AVTX (Avalo Therapeutics, Inc.)|ELDN (Eledon) - Net Profit|AGEN: Final Profit|Net Profit CLYM|Net Profit zurabio.com (ZURA)|Company Net Income aTyr Pharma ATYR|Final Profit ADAG|IMA - Company Net Income|Shattuck Labs, Inc. (STTK) - Net Income|EQ: Net Profit|Connect Biopharma Holdings Limited (CNTB) - Net Profit|Net Income IMUX|ATRA: Final Profit|Net Profit IFRX|Net Financial Result X4 Pharmaceuticals, Inc|Company Net Income Adicet Bio, Inc. ACET|CELU - Net Income|INMB - Company Net Income|Barinthus Biotherapeutics PLC (BRNS) - Net Income|KZR (Kezar Life Sciences, Inc) - Net Income|SAB Biotherapeutics Inc (SABS) - Net Profit|Company Net Income Akari Therapeutics|Company Profit ENLV (Enlivex Therapeutics, Ltd.)|Net Profit QTTB|GOVX - Company Net Income|Net Profit EDSA (Edesa)|Net Profit iBio Corporation IBIO|Carisma Tx - Net Profit|Profit After Tax XTLB|BOLT: Net Profit|Profit After Tax HCWB (HCW Biologics)|APVO (Aptevo Therapeutics, Inc.) - Net Profit|aimimmuno.com (AIM) - Net Financial Result|Company Net Income Aditxt (ADTX)|Net Income gribio.com GRI|Net Profit XRTX (XORTX Therapeutics)|Vyome Holdings Inc. (HIND) - Company Net Income|Revelation Bio - Net Profit|INDP (Indaptus Corp) - Company Profit|SCNI: Net Profit|CalciMedica (CALI) - Net Profit|ALLK (Allakos Inc) - Net Profit|HOOKIPA - Profit After Tax|Company Net Income IGM Biosciences, Inc. (IGMS)|Net Income iTeos Pharma ITOS|Net Profit OCEA (Ocean Biomedical, Inc.)|TCBP: Company Profit|THRD - Company Net Income